Category Archives: Medical Science

Home / Medical Science
3 Posts

Elysium Health was founded in 2014 by Dr. Leonard Guarente, the director of the Paul F. Glenn Center for Biology of Aging Research at MIT. Dr. Guarente has conducted significant research on the genetic and molecular causes of aging during his scientific career.

 

Elysium Health is a consumer health company that translates advances in science and technology into clinically-validated health products that work. Elysium works directly with world-class scientists from Harvard, Stanford, and Yale, who serve on Elysium’s Scientific Advisory Board and help guide the direction of the company. Elysium’s first health product is Basis—a daily supplement that is based on more than 25 years of aging research.

 

Basis is proven to increase and sustain levels of the coenzyme NAD+ in our cells. NAD+ is essential to many of our cellular functions like circadian rhythms, energy creation, and hundreds of others. As we age, our levels of NAD+ decline and those functions break down.

 

Elysium Health conducted a clinical trial to ensure the safety and effectiveness of Basis. During the trial, 120 people were divided into three equal groups. Group one took the recommended dose of Basis (two capsules daily), group two took double the recommended dose of Basis (four capsules daily), and group three took a placebo daily. The results demonstrated that taking the recommended daily dose of Basis over the course of several weeks increased levels of NAD+ in humans by an average of 40 percent. Taking double the recommended dose increased levels of the coenzyme by an average of 90 percent. (Read: Is an Anti-Aging Pill on the Horizon?)

 

Basis is available for purchase on Elysium Health’s website. Each individual jar contains a month’s worth of the supplement—60 capsules. One jar of Basis costs $60, but monthly subscriptions help bring that cost down to between $40 and $50 per month. Go Here to learn more.

 

More information on Elysium Health, the company’s team, and the science behind Basis can be found on Elysium’s website: https://www.elysiumhealth.com/basis

Elysium Health is a consumer health company that works directly with world-class scientists from institutions like Stanford and Harvard to translate advances in science and technology into clinically-validated health products that work. Elysium’s mission is to help people live healthier, longer.

 

Basis is a daily supplement created by Elysium Health that is proven to increase and sustain NAD+ levels in our cells. NAD+ is a coenzyme that is essential to many of our cellular functions, such as DNA protection, circadian rhythms, and energy creation. Our levels of NAD+ decline naturally as we get older and those functions break down.

 

Elysium Health was founded by Dr. Leonard Guarente, Eric Marcotulli, and Dan Alminana in 2014. Dr. Guarente serves as the chief scientist of Elysium Health, and he is also the director of the Paul F. Glenn Center for Biology of Aging Research at MIT. Marcotulli previously worked in venture capital and is now the CEO of Elysium. Alminana comes from investment banking and is the COO of the company.

 

To prove that Basis works, Elysium conducted a clinical trial in 2016. During the trial, 120 adults were divided into three groups. One group received a placebo. Another group received a daily dose (two capsules) of the supplement. The third group received double the daily dose (four capsules) of the supplement. The results demonstrated that adults who took the daily dose of Basis over the course of several weeks saw their NAD+ levels rise by an average of 40 percent. Read This Article for more information.

 

Basis is available for purchase on Elysium Health’s website. Each jar contains a month’s worth of the supplement, 60 capsules, the company sells Basis as an individual purchase for $60 or monthly subscriptions. A regular monthly subscription costs $50 per month. A six-month subscription to Basis costs $270, bringing the cost per month down to $45, and a one-year costs $480, or $40 per month.

 

For more information about Elysium Health, the scientists working with the company, or the science behind basis, visit Elysium’s website: https://www.elysiumhealth.com/basis

Matthew Autterson is known as the leader of Colorado’s business community and one of its most generous philanthropists. Matthew Autterson graduated in the University of the prestigious Michigan Stet, in Finances, where he learned to become a better financial administrator, and this laid the foundation of his business acumen that allowed him to achieve success and use it to fund several philanthropic deeds, especially in the world of medicine.

 

Matthew Autterson began his career in business and finances at First Trust Corporation, Fiserv’s subsidiary. Two years after graduating from the Michigan Stet School of Finances, Mr. Autterson left the company First Trust Corporation to join another smaller group whose goal is to permit a Colorado State company. It was meant to be a part of a financial services company in NY called the Integrated Resources Inc, where Mr. Autterson improved his business skills. There, he joined the Resources Trust Company and became the President of the corporation.

 

Three years after that, already a strong businessman with a solid foundation, Broad Inc. purchased Resources Trust Company. Later AIG decided to purchase SunAmerica for billions of dollars because of their worth in the market.

 

Throughout all of these purchases and acquisitions, Resources Trust Company, through the leadership of Matthew Autterson, had over a billion dollars in deposits and almost a thousand employees and partners, with billions in custodial assets. The company would later be purchased by Fiserve, from AIG, three years after AIG bought SunAmerica.

 

Mr. Autterson believed it was time to give back and help those in need. His generous philanthropic deeds are represented by various leadership roles in the world of medicine and research such as being part of the Board of the Webb-Waring Foundation, Denver Zoological Foundation, and the renowned Denver Zoo. Mr. Autterson was also the Chairman of Denver Hospice’s Board of Directors.

 

Lately, his heart has been touched by the people suffering from neuropathic pain. Neuropathic pain is a cruel medical condition wherein the patient continually suffers from crippling grief. People with this situation have been forced to quit their jobs and live their lives in despair. Thankfully Dr. Scott Falci is there, often as a last result. Dr. Scott Falci has been able to perform surgeries to patients with neuropathic pain, but he aims to develop a drug that can cure a patient without having to undergo invasive surgery. This is why he founded CNS Bioscience where Mr. Autterson is the President, Board member, and the CEO. Mr. Autterson has described this as one of his philanthropic works where he is most proud of.  Read This for additional information.